Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
J. bras. nefrol; 40 (2), 2018
Abstract Hydralazine is a direct-acting vasodilator, which has been used in treatment for hypertension (HTN) since the 1950s. While it is well known to cause drug-induced lupus (DIL), recent reports are indicating the emergence of the drug-induced anti-neutrophil cytoplasmic antibody (ANCA) associated va...